BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8146182)

  • 1. Protein S binds to and inhibits factor Xa.
    Heeb MJ; Rosing J; Bakker HM; Fernandez JA; Tans G; Griffin JH
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2728-32. PubMed ID: 8146182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C.
    Heeb MJ; Mesters RM; Tans G; Rosing J; Griffin JH
    J Biol Chem; 1993 Feb; 268(4):2872-7. PubMed ID: 8428962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
    Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
    Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
    J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
    Hackeng TM; van 't Veer C; Meijers JC; Bouma BN
    J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system.
    Hayashi T; Nishioka J; Suzuki K
    Biochim Biophys Acta; 1995 Dec; 1272(3):159-67. PubMed ID: 8541347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human protein S cleavage and inactivation by coagulation factor Xa.
    Long GL; Lu D; Xie RL; Kalafatis M
    J Biol Chem; 1998 May; 273(19):11521-6. PubMed ID: 9565566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin.
    Taneda H; Andoh K; Nishioka J; Takeya H; Suzuki K
    J Biochem; 1994 Sep; 116(3):589-97. PubMed ID: 7852276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
    Mesters RM; Heeb MJ; Griffin JH
    Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.
    Deguchi H; Sinha RK; Marchese P; Ruggeri ZM; Zilberman-Rudenko J; McCarty OJT; Cohen MJ; Griffin JH
    Blood; 2016 Oct; 128(14):1870-1878. PubMed ID: 27421960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of human factors X and Xa to HepG2 and J82 human tumor cell lines. Evidence that factor Xa binds to tumor cells independent of factor Va.
    Sakai T; Kisiel W
    J Biol Chem; 1990 Jun; 265(16):9105-13. PubMed ID: 2160956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of venom phospholipases: the strongly anticoagulant phospholipase A(2) from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex.
    Kerns RT; Kini RM; Stefansson S; Evans HJ
    Arch Biochem Biophys; 1999 Sep; 369(1):107-13. PubMed ID: 10462445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.
    Heeb MJ; Prashun D; Griffin JH; Bouma BN
    FASEB J; 2009 Jul; 23(7):2244-53. PubMed ID: 19244162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular interaction site on procoagulant myosin for factor Xa-dependent prothrombin activation.
    Deguchi H; Guo Z; Hayat M; Pflimlin E; Lear S; Shen W; Griffin JH
    J Biol Chem; 2019 Oct; 294(41):15176-15181. PubMed ID: 31481465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.